Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

jermainejackson

Rank: Treasurer [?]

Points: 267 [?]

Votes: 18 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Financials

posted on Aug 07, 2019 05:15PM

The last financials posted by Zenith on Sedar and their website are Jan 2019. I assume since they are not a public company there is no way to access more timely info?

1 Recommendations

Re: Financials

KOO-KOO2

Aug 09, 2019 10:26AM